We next investigated whether EGFR regulated the phenotype of HCC cells via miR-222-5p-targeting CYLD in experiments where HepG2 cells were with sh-EGFR and miR-222-5p inhibitor. This evidence concerns the gene CYLD and hepatocellular carcinoma.